Cargando…
The Role and Therapeutic Targeting of CCR5 in Breast Cancer
The G-protein-coupled receptor C-C chemokine receptor 5 (CCR5) functions as a co-receptor for the entry of HIV into immune cells. CCR5 binds promiscuously to a diverse array of ligands initiating cell signaling that includes guided migration. Although well known to be expressed on immune cells, rece...
Autores principales: | Hamid, Rasha, Alaziz, Mustafa, Mahal, Amanpreet S., Ashton, Anthony W., Halama, Niels, Jaeger, Dirk, Jiao, Xuanmao, Pestell, Richard G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526962/ https://www.ncbi.nlm.nih.gov/pubmed/37759462 http://dx.doi.org/10.3390/cells12182237 |
Ejemplares similares
-
An Update on Glioblastoma Biology, Genetics, and Current Therapies: Novel Inhibitors of the G Protein-Coupled Receptor CCR5
por: Lah Turnšek, Tamara, et al.
Publicado: (2021) -
Leronlimab, a humanized monoclonal antibody to CCR5, blocks breast cancer cellular metastasis and enhances cell death induced by DNA damaging chemotherapy
por: Jiao, Xuanmao, et al.
Publicado: (2021) -
Mitochondrial mass and DNA repair in breast cancer stem cells
por: Pestell, Richard G., et al.
Publicado: (2015) -
Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors
por: Patra, Sayani, et al.
Publicado: (2021) -
The CCL5/CCR5 axis promotes metastasis in basal breast cancer
por: Velasco-Velázquez, Marco, et al.
Publicado: (2013)